iShares Biotechnology ETF $IBB Stock Position Lessened by Realta Investment Advisors

Realta Investment Advisors decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 89.6% in the 1st quarter, HoldingsChannel reports. The firm owned 456 shares of the financial services provider’s stock after selling 3,941 shares during the quarter. Realta Investment Advisors’ holdings in iShares Biotechnology ETF were worth $77,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Brighton Jones LLC bought a new position in iShares Biotechnology ETF in the 4th quarter valued at about $201,000. AQR Capital Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $455,000. Millennium Management LLC raised its position in shares of iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after buying an additional 143,893 shares in the last quarter. M&T Bank Corp lifted its stake in shares of iShares Biotechnology ETF by 39.3% in the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after acquiring an additional 750 shares during the period. Finally, Walleye Capital LLC lifted its stake in shares of iShares Biotechnology ETF by 26.8% in the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after acquiring an additional 985 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.0%

iShares Biotechnology ETF stock opened at $187.38 on Monday. iShares Biotechnology ETF has a 12-month low of $125.70 and a 12-month high of $188.69. The firm has a 50 day simple moving average of $171.45 and a 200-day simple moving average of $171.04.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were given a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.